Following a Friday hearing on drug prices and their impact on patients, Rep. Elijah Cummings, House Oversight and Reform Committee chairman, announced plans for a hearing in which pharmaceutical executives would be called to testify on prices, The Hill reports.
“I want to tell you, this may make you feel some hope: We’re going to have the drug company folks sitting in the same seats as soon as we come back,” Cummings said. “And we’re going to try to understand some of why they’re doing what they’re doing.”
The House returns from recess in September.
No details were provided on which companies Cummings planned to invite, according to the report.
To read the full report on The Hill, click here.